GlassScriptPhysician profile
Jina C Schaff
NPI 1265581797
$5,228.84
in general payments reported to CMS, 2019-2025
15 companies · $198 in 2025
The $198 reported for 2025 was less than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $568 · 2020: $230 · 2021: $898 · 2022: $1,154 · 2023: $1,810 · 2024: $372 · 2025: $198.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,492 · Travel and Lodging: $887.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,491.94 |
| Travel and Lodging | $887.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coopervision INC. | $2,102.01 | 2019-2025 | Cvi Contact Lens, Myday Contact Lens, Paragon Hds100 Contact Lens |
| Alcon Vision LLC | $874.16 | 2019-2025 | Precision 1, Total30, Dailies |
| Johnson & Johnson Vision Care, INC. | $620.94 | 2019-2025 | Acuvue |
| Johnson & Johnson Surgical Vision, INC. | $516.62 | 2022 | |
| Bausch & Lomb Americas INC. | $404.71 | 2022-2025 | Infuse, Xiidra |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $183.49 | 2019-2021 | |
| Sun Pharmaceutical Industries INC. | $158.48 | 2022-2024 | |
| Apellis Pharmaceuticals, INC. | $122.55 | 2024 | Syfovre |
| Optovue, INC. | $66.66 | 2019 | |
| Biotissue Holdings INC. | $43.17 | 2022-2023 | |
| Allergan, INC. | $40.54 | 2021-2022 | |
| Tarsus Pharmaceuticals, INC. | $39.43 | 2024-2025 | Xdemvy |
| Ortho-Clinical Diagnostics, INC. | $21.55 | 2024 | |
| Novartis Pharmaceuticals Corporation | $18.40 | 2023 | |
| Abb Con-Cise Optical Group LLC | $16.13 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jina Schaff listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.